Policy & Regulation
Ryvu Therapeutics wins FDA orphan drug designation for SEL120 to treat acute myeloid leukemia
30 March 2020 - Biopharmaceutical company Ryvu Therapeutics (WSE:RVU) reported on Saturday the receipt of US Food and Drug Administration (FDA) orphan drug designation (ODD) to advance SEL120 to addre...
Saniona announces collaboration agreement with Boehringer Ingelheim in schizophrenia
27 March 2020 - Saniona AB (STO:SANION), a clinical stage biopharmaceutical company focused on rare diseases of the central nervous system, announced on Thursday a new research collaboration with Boeh...
Innoplexus uses AI discovery platform to find potential combinations of prior approved drugs for COVID-19
27 March 2020 - AI-based drug discovery and development company Innoplexus AG on Thursday provided an update of the first results from its artificial intelligence enabled search for a COVID-19 antivir...
Innoplexus reveals certain first results in artificial intelligence enabled search for COVID-19 treatment
27 March 2020 - Innoplexus AG, a global AI-based platform for drug discovery and development, has revealed certain first results in its artificial intelligence enabled search for a COVID-19 antiviral ...
US FDA grants Orphan Drug Designation to PR Applied Pharma Research's APR-OD031
27 March 2020 - The United States Food and Drug Administration (FDA) has granted Orphan Drug Designation to Switzerland-based APR Applied Pharma Research SA's drug candidate, APR-OD031, intended ...
Evolve BioSystems Inc partners with Janssen to study B. infantis EVC001 in reduction of childhood atopic dermatitis
27 March 2020 - Human health company Evolve BioSystems Inc said on Thursday that it plans to conduct a clinical study in children at risk for developing atopic dermatitis in partnership with Janssen R...
Related Headlines

Relief Therapeutics partners with NeuroRx to file IND for phase 2 trial of RLF-100 for COVID-19

APR Applied Pharma Research granted FDA orphan drug designation for APR-OD031 for treating PKU

Inovio Reports Positive Interim Phase 2 VGX-3100 Results in Patients with HPV-associated Anal Dysplasia

Decibel Therapeutics Publishes Results from Early-Stage Study of Therapy Designed to Prevent Hearing Loss Associated with Cisplatin Chemotherapy

US Food and Drug Administration Approves Bristol Myers Squibb's Zeposia for Relapsing Forms of Multiple Sclerosis

AgNovos Healthcare Receives Breakthrough Designation for Spine Device

Quidel's Lyra SARS-CoV-2 Assay Receives Authorisation from US FDA for Expanded Use for Molecular Detection of COVID-19

Forge Therapeutics signs research collaboration and option agreement with Hoffmann-La Roche

Exelixis Partner Takeda Receives Approval in Japan for Cabometyx Tablets for the Treatment of Curatively Unresectable or Metastatic Renal Cell Carcinoma

Bruker Launches CE-IVD Marked Genesig Assay Kit for the Detection of the SARS-CoV-2 Virus

Alnylam Pharmaceuticals, Gen Sign Distribution Agreement in Turkey for Onpattro 'Gene-Silencing' RNAi Therapeutic

Stemcell Technologies Provides Support to Sequence the COVID-19 Virus, Accelerating Vaccine Development

Nuclein to Expedite Commercialisation of Hand-Held PCR Test to Aid in COVID-19 Pandemic

Crescita Therapeutics to take measures in response to COVID-19

Partner Therapeutics to assess Leukine in SARPAC trial for COVID-19 Associated Respiratory Illness